Cover Image

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy

As respiratory syncytial virus (RSV) vaccine distribution gains traction in Europe and Italy, healthcare workers (HCWs) can strategize about vaccine promotion to increase uptake among patients at risk of RSV consequences, such cardiac patients. This cross-sectional survey investigated the knowledge...

Full description

Saved in:

Bibliographic Details
Main Authors:	Domenico Ponticelli (Author), Lorenzo Losa (Author), Ippazio Cosimo Antonazzo (Author), Anna Zampella (Author), Fabio Di Marino (Author), Gaetano Mottola (Author), Mara Noemi Fede (Author), Fortuna Gallucci (Author), Roberto Magliuolo (Author), Antonio Rainone (Author), Antonella Arcari (Author), Carmine Del Giudice (Author), Pietro Ferrara (Author)
Format:	Book
Published:	MDPI AG, 2024-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
Published: (2020)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
by: Andrea Gastaldi, et al.
Published: (2021)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
by: Qiang Wang, et al.
Published: (2024)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
by: Xiao Li, et al.
Published: (2024)

An outbreak of RSV infections in a neonatology clinic during the RSV-season
by: Liliya Vakrilova, et al.
Published: (2021)

The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany - a critical view
by: Heudorf, Ursel, et al.
Published: (2024)

Respiratory syncytial virus (RSV) disease - new data needed to guide future policy
by: Louis Bont, et al.
Published: (2015)

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain
by: Jaime Jesús Pérez Martín, et al.
Published: (2024)

Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
by: Lu Wang, et al.
Published: (2021)

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody
by: Bryony Treston, et al.
Published: (2024)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
by: Johan L. Van Der Plas, et al.
Published: (2020)

Serological Survey Of Respiratory Syncytial Virus (RSV) Among Children In Lorin North-Central, Nigeria.
by: Odebisi- Omokanye, et al.
Published: (2018)

The Differences Between RSV and no RSV Acute Bronchiolitis in Hospitalized Infants: A Cross-Sectional Study
by: Evangelos Christou, et al.
Published: (2022)

The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
by: Joyce U. Nyiro, et al.
Published: (2024)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
by: Lori M. Cullen, et al.
Published: (2017)

An epidemiological study of RSV infection in the Gambia
by: Weber Martin W., et al.
Published: (2002)

A multifaceted approach to RSV vaccination
by: Jorge C. G. Blanco, et al.
Published: (2018)

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
by: Nienke M Scheltema, MD, et al.
Published: (2017)

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
by: Simões Eric AF, et al.
Published: (2011)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries
by: Rachel Cevigney, et al.
Published: (2021)

Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
by: Ravasio Roberto, et al.
Published: (2009)

Diagnostic utility of BINAX NOW RSV - an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
by: Jonathan Nteimam
Published: (2006)

Ongoing disruption of RSV epidemiology in children in Switzerland
by: Patrick M. Meyer Sauteur, et al.
Published: (2024)

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina
by: Suada Heljic, et al.
Published: (2016)

Strategies for active and passive pediatric RSV immunization
by: Katherine M. Eichinger, et al.
Published: (2021)

Identifying climatic drivers of respiratory syncytial virus (RSV) seasonality in Antananarivo, Madagascar, 2011-2021: a sentinel surveillance study
by: Jean-Michel Heraud, et al.
Published: (2024)

Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey
by: Jo Won Jung
Published: (2011)

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines
by: Rupali J. Limaye, et al.
Published: (2023)

Relevance of RSV in hospitalized adults and the need for continued testing
by: Katherine Miller, et al.
Published: (2022)

Maternal RSV vaccine development. Where to from here?
by: Ahinsa Gunatilaka, et al.
Published: (2021)

RSV awareness, risk perception, causes, and terms: Comment
by: Somsri Wiwanitkit, et al.
Published: (2023)

Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials
by: Sandy Lewis, et al.
Published: (2018)

Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
by: Cosimo Antonazzo, Ippazio
Published: (2019)

Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
by: Cosimo Antonazzo, Ippazio
Published: (2019)

Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study
by: Deema Gashgarey, et al.
Published: (2024)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
by: Joyce U. Nyiro, et al.
Published: (2020)

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States
by: Martine C. Maculaitis, et al.
Published: (2024)

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection
by: Su-Hwa Lee, et al.
Published: (2023)